Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

2009 Recipient Of Minority Scholar Award Begins Clinical Research On Leukemia
Alejandro Gutierrez, MD, is the third recipient of the ASH-AMFDP grant, an award designed to help increase the number of underrepresented minority scholars in the field of hematology, and will begin his research into the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) this month. The award, the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation, provides four years of support, including an annual stipend of up to $75,000 and an annual grant of more than $29,000 for research activities.
generic viagra online
Vetericyn Inc. Launches Equine Wound & Infection Product Utilizing FDA-Cleared Technology
Vetericyn Inc., a California-based animal healthcare company, has announced the launch of its new Vetericyn™ equine product, available in a 16-ounce trigger spray for horses. Vetericyn™ utilizes an FDA-cleared technology that has been used to successfully treat over one million human patients without a single serious adverse effect. Now, the innovative topical wound-care product is available to the animal healthcare market.
News of the day
Context Is Key: Differential PI3K Signaling And Consequences For Targeted Therapy
In the July 15th issue of G and D, Dr. Suzanne Baker (St. Jude Children"s Research Hospital) and colleagues report on their surprising discovery of cell-type specificity of PI3K signaling in the mammalian brain. This finding highlights the complexity of this clinically significant cell signaling pathway, and its relevance to the design of small molecule PI3K pathway inhibitors, to both maximize efficacy and minimize side effects.
Public Health

Researchers Determine Predicting Factors Of Positive Lung Cancer Diagnoses In Chest Radiographs

A study published in the June 2009 issue of the Journal of Thoracic Oncology determined several predictors of a positive lung cancer diagnosis after having an abnormal chest x-ray. Dr. Martin Carl Tammemagi of Brock University in Ontario and his team of US researchers examined the chest radiographs of 12,314 individuals obtained through the National Cancer Institute"s Prostate Lung Colorectal Ovarian Cancer Screening Trial (PLCO). They found that older age, lower education levels and a longer smoking history were all associated with a "true positive" diagnosis for lung cancer in those individuals with an abnormal screening chest radiograph. A "true positive" radiograph represents an accurate reading for lung cancer. Other factors that contributed to a "true positive" diagnosis include a family history of lung cancer and a suspicious mass in the upper/middle chest region. "The factors will be particularly valuable to those health care providers and clinicians identifying patients with abnormal chest x-rays that might indicate possible lung cancer." says Dr. Tammemagi "An earlier diagnosis is expected to lead to a more favorable outcome for the patient, so it is our hope that predictors will assist clinicians in calling for the most necessary and timely tests." This study was conducted in collaboration with The National Cancer Institute, Georgetown University and the University of Minnesota. Bethany Fischer International Association for the Study of Lung Cancer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009